•  
  •  
  •  
  •  

2025-10-16 17:10:40

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Swaraj Engines Ltd Q2 FY2026 net profit at Rs. 49.68 crores
  • Mastek Ltd Q2FY26 consolidated PAT up QoQ at Rs. 97.45 crores
  • Indian Bank posts consolidated net profit of Rs. 3040.53 crores in Q2 FY2025-26
  • D B Corp Ltd Q2 FY2026 consolidated net profit rises to Rs. 93.45 crores
  • Indian Overseas Bank reports consolidated PAT of Rs. 1227.90 crores in Q2 FY2026

Keywords Selected:  ABS

Research

  • Q4FY22 Result Update – Laurus Labs - ICICI Direct

Stock Report

  • Paul Merchants Collaborates with Mastercard and Pine Labs to Redefine International Travel Payments with Launch of the Paul Merchants Global Currency Card
  • Haleos Labs Limited successfully completes ANVISA audit at Unit-1
  • Dr Lal PathLabs Limited approves acquisition of property in New Delhi
  • Qualitek Labs Limited receives order from Indian Oil Corporation Ltd
  • Jyothy Labs Ltd launches Liquid Deterget 'Dr. Wool®'
  • Aarti Pharmalabs Ltd inaugurates phase 1 of greenfield manufacturing facility
  • Dr. Lal PathLabs Pioneers AI Integration in Cancer Diagnosis in India
  • Laurus Labs Ltd allotted 531.77 acres of land by the Government of Andhra Pradesh
  • Laurus Labs Ltd consolidated Q1 FY2026 PAT at Rs. 163.02 crores
  • Vimta Labs Ltd Q1 FY2025-26 PAT climbs to Rs. 18.89 crores
  • Dr. Lal PathLabs strengthens its genomics capabilities with Illumina's NovaSeq X Series
  • CarTrade Labs to Drive Innovation and Shape the Future of Technology
  • Vimta Labs Ltd fixes June 13, 2025 as record date for 1:1 bonus issue
  • Jyothy Labs Ltd recommends dividend of Rs. 3.50
  • Jyothy Labs Ltd Q4 FY25 consolidated net profit drops to Rs. 76.30 crores
  • Vimta Labs Ltd to invest Rs. 50 crores to Biologics CDMO business foray
  • Vimta Labs Ltd recommends 1:1 bonus issue
  • Vimta Labs Ltd recommends dividend of Rs. 2
  • Vimta Labs Ltd Q4 FY2025 PAT at Rs. 18.31 crores
  • Dr. Lal PathLabs Limited recommends final dividend of Rs. 6
  • Dr. Lal Path Labs Ltd Q4FY25 consolidated PAT jumps to Rs. 154.8 crores
  • Laurus Labs Limited approves 2nd interim dividend of Rs. 0.80
  • Laurus Labs Ltd posts Rs. 232.77 crores consolidated PAT in Q4FY25
  • Aarti Pharmalabs becomes 6th Indian Pharma/CDMO to Earn SBTi Approval for all 3 Scopes

Latest Post

  • Swaraj Engines Ltd Q2 FY2026 net profit at Rs. 49.68 crores
  • Mastek Ltd Q2FY26 consolidated PAT up QoQ at Rs. 97.45 crores
  • Indian Bank posts consolidated net profit of Rs. 3040.53 crores in Q2 FY2025-26
  • D B Corp Ltd Q2 FY2026 consolidated net profit rises to Rs. 93.45 crores
  • Indian Overseas Bank reports consolidated PAT of Rs. 1227.90 crores in Q2 FY2026


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024